
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
21 Incredibly Interesting Contemplations To Observe Consistently - 2
America's Confided in Fridge in 2024 - 3
Merz: 80% of Syrians in Germany should return in three years - 4
See the metal guts of a satellite in this wild X-ray view | Space photo of the day for Dec. 4, 2025 - 5
He suddenly couldn't speak in space. NASA astronaut says his medical scare remains a mystery
Medicine doesn’t just have ‘conscientious objectors’ − there are ‘conscientious providers,’ too
The 10 Most Famous Works of art Ever
Doritos and Cheetos debut 'NKD' options, without artificial colors or flavors
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
What to know about MIT professor Nuno Loureiro and the investigation into his shooting
Civil rights leader Jesse Jackson hospitalized, family requests prayers
Germany paves the way for tighter EU asylum rules
Bolsonaro says hallucinatory effects of meds made him tamper with ankle tag
Best Internet based Course for Learning Another Dialect: Which Stage Do You Like?













